An Phat Bioplastics JSC (HOSE:AAA)
Vietnam · Delayed Price · Currency is VND 7,750.00
-20.00 (-0.26%)
At close: Feb 9, 2026
An Phat Bioplastics JSC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,728,147 | 12,782,231 | 12,621,514 | 15,290,297 | 13,143,110 | |
Revenue Growth (YoY) | -16.07% | 1.27% | -17.45% | 16.34% | 76.93% |
Cost of Revenue | 9,235,314 | 11,298,125 | 11,512,821 | 14,204,057 | 11,841,734 |
Gross Profit | 1,492,833 | 1,484,106 | 1,108,693 | 1,086,240 | 1,301,375 |
Selling, General & Admin | 944,024 | 1,097,163 | 796,338 | 913,705 | 933,290 |
Operating Expenses | 944,024 | 1,097,163 | 796,338 | 913,705 | 933,290 |
Operating Income | 548,810 | 386,943 | 312,356 | 172,535 | 368,086 |
Interest Expense | -150,616 | -168,056 | -210,818 | -181,957 | -160,990 |
Interest & Investment Income | 73,371 | 108,059 | 176,215 | 100,707 | 108,766 |
Earnings From Equity Investments | 43,908 | 56,720 | 52,941 | 57,679 | 22,873 |
Currency Exchange Gain (Loss) | 88,091 | 133,118 | 41,904 | 46,290 | 45,262 |
Other Non Operating Income (Expenses) | -66,343 | -105,168 | -6,142 | -8,344 | -18,183 |
EBT Excluding Unusual Items | 537,221 | 411,616 | 366,457 | 186,911 | 365,813 |
Gain (Loss) on Sale of Investments | - | - | - | - | 29,000 |
Gain (Loss) on Sale of Assets | - | 3,908 | 2,392 | -1,846 | 2,052 |
Other Unusual Items | - | 42.57 | 9,046 | 1,001 | 1,003 |
Pretax Income | 537,221 | 415,566 | 377,896 | 186,066 | 397,868 |
Income Tax Expense | 113,299 | 95,784 | 68,702 | 68,775 | 73,725 |
Earnings From Continuing Operations | 423,921 | 319,782 | 309,194 | 117,291 | 324,143 |
Minority Interest in Earnings | -51,009 | 48,799 | -19,783 | 35,308 | -33,902 |
Net Income | 372,913 | 368,581 | 289,411 | 152,599 | 290,241 |
Preferred Dividends & Other Adjustments | - | - | 40,398 | 8,757 | 52,916 |
Net Income to Common | 372,913 | 368,581 | 249,013 | 143,842 | 237,325 |
Net Income Growth | 1.18% | 27.36% | 89.65% | -47.42% | 10.68% |
Shares Outstanding (Basic) | 394 | 382 | 382 | 352 | 292 |
Shares Outstanding (Diluted) | 394 | 382 | 382 | 352 | 292 |
Shares Change (YoY) | 3.00% | - | 8.46% | 20.67% | 32.65% |
EPS (Basic) | 947.10 | 964.18 | 651.40 | 408.13 | 812.54 |
EPS (Diluted) | 947.10 | 964.00 | 651.00 | 408.00 | 812.54 |
EPS Growth | -1.75% | 48.08% | 59.56% | -49.79% | -17.26% |
Free Cash Flow | -542,161 | -79,202 | 1,972,033 | -71,231 | -224,991 |
Free Cash Flow Per Share | -1376.94 | -207.19 | 5158.68 | -202.11 | -770.31 |
Dividend Per Share | - | 300.000 | - | - | - |
Gross Margin | 13.91% | 11.61% | 8.78% | 7.10% | 9.90% |
Operating Margin | 5.12% | 3.03% | 2.48% | 1.13% | 2.80% |
Profit Margin | 3.48% | 2.88% | 1.97% | 0.94% | 1.81% |
Free Cash Flow Margin | -5.05% | -0.62% | 15.62% | -0.47% | -1.71% |
EBITDA | 1,050,440 | 786,202 | 643,326 | 483,536 | 684,021 |
EBITDA Margin | 9.79% | 6.15% | 5.10% | 3.16% | 5.20% |
D&A For EBITDA | 501,631 | 399,260 | 330,971 | 311,001 | 315,935 |
EBIT | 548,810 | 386,943 | 312,356 | 172,535 | 368,086 |
EBIT Margin | 5.12% | 3.03% | 2.48% | 1.13% | 2.80% |
Effective Tax Rate | 21.09% | 23.05% | 18.18% | 36.96% | 18.53% |
Revenue as Reported | 10,728,147 | 12,782,231 | 12,621,514 | 15,290,297 | 13,143,110 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.